Rituximab is successful in an HIV-positive patient with MuSK myasthenia gravis.
| Data(s) |
2011
|
|---|---|
| Identificador |
http://serval.unil.ch/?id=serval:BIB_29B56BFBD556 isbn:1526-632X (Electronic) pmid:21339503 doi:10.1212/WNL.0b013e31820d6290 isiid:000287574500018 http://my.unil.ch/serval/document/BIB_29B56BFBD556.pdf http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_29B56BFBD5566 |
| Idioma(s) |
en |
| Direitos |
info:eu-repo/semantics/openAccess |
| Fonte |
Neurology, vol. 76, no. 8, pp. 757-758 |
| Palavras-Chave | #Antibodies/blood; Antibodies, Monoclonal, Murine-Derived/therapeutic use; Female; HIV Seropositivity/complications; HIV Seropositivity/drug therapy; Humans; Immunologic Factors/therapeutic use; Myasthenia Gravis/complications; Myasthenia Gravis/drug therapy; Receptor Protein-Tyrosine Kinases/immunology; Receptors, Cholinergic/immunology; Young Adult |
| Tipo |
info:eu-repo/semantics/article article |
